Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0034063 (
pulmonary edema
)
10,665
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Phosgene is a toxic gas that is widely used in modern industry, and its inhalation can cause severe
pulmonary edema
. There is no effective clinical treatment because the mechanism of phosgene-induced
pulmonary edema
still remains unclear. Many studies have demonstrated that the Na(+)/K(+)-ATPase plays a critical role in clearing
pulmonary edema
and the inhibition of Na(+)/K(+)-ATPase protein expression has been found in many other
pulmonary edema
models. In the present study, after the mice were exposed to phosgene, there was serious
pulmonary edema
, indicating the dysfunction of the ATPases in mice. However, in vitro enzyme study showed that there were increases in the activities of the Na(+)/K(+)-ATPase and Ca(2+)-ATPase. Further investigation showed that the ATP content and mitochondrial respiratory control ratio (RCR) in the lungs decreased significantly. The oxidative stress product, malondialdehyde (MDA), increased while the antioxidants (GSH, SOD, and
TAC
) decreased significantly. These results indicate that mitochondrial respiration is the target of phosgene. The dysfunction of ATPases due to impaired mitochondrial respiration may be a new mechanism of phosgene-induced
pulmonary edema
.
...
PMID:The dysfunction of ATPases due to impaired mitochondrial respiration in phosgene-induced pulmonary edema. 1816 70